Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)

Autor: Håvard Midgard, Kjell Arne Johansson, Christian Ohldieck, Lars Thore Fadnes, Rafael Alexander Mo Leiva, Fatemeh Chalabianloo, Peter Vickerman, Olav Dalgard, Svetlana Skurtveit, Jørn Henrik Vold, Else-Marie Løberg, Christer Frode Aas, Ole Jørgen Scheie Lygren

Publikováno v: BMC Infectious Diseases
Lim, A G 2019, ' Integrated treatment of hepatitis C virus infection among people who inject drugs : study protocol for a randomised controlled trial (INTRO-HCV) ', BMC Infectious Diseases, vol. 19, no. 1, pp. 943 . https://doi.org/10.1186/s12879-019-4598-7
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
19:943

Background A large proportion of people who inject drugs (PWID) living with hepatitis C virus (HCV) infection have not been treated. It is unknown whether inclusion of HCV diagnostics and treatment into integrated substance use disorder treatment and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1f306d442ea3e9249dc76b5005b9b93
https://pubmed.ncbi.nlm.nih.gov/31703669